ACOR
Acorda Therapeutics, Inc.
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
154 hedge funds and large institutions have $1.09B invested in Acorda Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 56 increasing their positions, 54 reducing their positions, and 23 closing their positions.
Holders
154
Holders Change
-3
Holders Change %
-1.91%
% of All Funds
3.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
56
Reduced
54
Closed
23
Calls
$4.38M
Puts
$12.7M
Net Calls
-$8.29M
Net Calls Change
-$6.73M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$11.2M |
| 2 |
HEC
2
Hudson Executive Capital
New York
|
$28.2M |
| 3 |
3
Norges Bank
Oslo,
Norway
|
$20.8M |
| 4 |
4
Dimensional Fund Advisors
Austin,
Texas
|
$63.4M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$52.6M |
